Yuvraj

Tissue Solutions Announces New CEO

We are pleased to announce the appointment of Dr Morag McFarlane as chief executive officer of Tissue Solutions Ltd. Morag has...

Ferrer licenses commercialisation rights for Ozenoxacin in the United States to Medimetriks Pharmaceuticals Inc.

Ferrer, a privately-held Spanish pharmaceutical company today announces that it has licensed commercialisation rights for Ozenoxacin one per cent cream in the United States...

Adocia announces financial results for 2013

Adocia announces today its annual financial results for 2013. The financial statements were approved by the board of directors on March 21, 2014 and...

CiToxLAB appoints John C. Kapeghian as senior director of toxicology in North America

This appointment makes the Montreal site attractive to North American clients and boosts CiToxLAB’s expertise in preclinical development and regulatory affairs. ...

Adocia announces preliminary positive clinical results for its combination of long-acting insulin Glargine and fast-acting insulin analog Lispro, Biochaperone(R) Combo

Adocia’s BioChaperone Combo is the first product combining insulin Glargine with a fast-acting insulin analogPhase I/II clinical trial demonstrates proof of concept in patients...

UBM to Launch Southeast Asia’s Leading International Beauty Trade Show In Thailand

BANGKOK Feb. 25 2014 - UBM Asia is pleased to announce the launch of ASEANbeauty the only beauty trade event supported by the Thai...

The Most Complete Information on America’s Nursing Facilities

WASHINGTON: U.S. News & World Report publisher of Best Hospitals and Best Children's Hospitals today released its Best Nursing Homes 2014 highlighting the top...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read